Budget impact analysis for the Health Care Package by using MammaPrint in Belgium

  Publication: ESMO BREAST CANCER CONGRESS 2022 Authors De Lameillieure Read More

kevin2024-03-25T11:22:52-04:00May 5th, 2022|Evidence, Healthcare Economics, Other|

Read More

Equivalence of NGS-based MammaPrint 70-gene signature risk of recurrence and BluePrint 80-gene signature of molecular subtyping tests to the centralized microarray tests

Publication: ESMO BREAST CANCER CONGRESS 2022 Authors Esther Schuler(1), Read More

kevin2024-03-07T10:49:21-05:00May 5th, 2022|Evidence, Other, Validation|

Read More

Durvalumab + olaparib + paclitaxel in High-risk HER2-negative ESBC: I-SPY2 trial results

I-SPY2 Trial, Cancer Cell 39, 989–998, 2021 Authors: Pusztai et al.

Read More

Karen Guzdzial2024-06-14T12:26:51-04:00July 27th, 2021|Evidence, I-SPY2, Immunotherapy, Neoadjuvant, Other|

Read More

Gene expression associated with lymphovascular invasion and genomic risk in early-stage breast cancer

PUBLICATION: ASCO 2021 Authors Nina D’Abreo1,2, Abhinav Rohatgi1,2, Douglas Read More

kevin2024-03-25T07:58:41-04:00July 7th, 2021|Evidence, Other|

Read More

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles (FLEX): A real-world dataset and investigator-initiated protocols in ESBC

  Publication: St. Gallen Authors: Jennifer A. Crozier, Lisa Blumencranz, Read More

kevin2024-03-07T10:48:15-05:00March 17th, 2021|Evidence, FLEX TIPS, Other|

Read More

Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens

Publication: St Gallen   Authors: M. Kleijn, J. McKelley, Read More

kevin2024-03-07T10:52:34-05:00March 17th, 2021|Evidence, Other, Validation|

Read More

The FLEX real world data platform explores new gene expression profiles and investigator-initiated protocols in early stage breast cancer

Publication: Miami Breast Authors: Pat Whitworth, Jennifer A. Crozier, Robert Read More

kevin2024-03-07T10:53:51-05:00March 8th, 2021|Evidence, FLEX TIPS, Other|

Read More

• 

  Racial disparities within Basal-type breast cancer: clinical and molecular features of African American and Caucasian obese patients

  Gallery

  Racial disparities within Basal-type breast cancer: clinical and molecular features of African American and Caucasian obese patients

  Evidence, Other, Racial Disparities

Racial disparities within Basal-type breast cancer: clinical and molecular features of African American and Caucasian obese patients

  PUBLICATION: SABCS 2020 AUTHORS: Dipali Sharma, Lisa E. Blumencranz, Read More

kevin2024-03-25T08:00:27-04:00December 29th, 2020|Evidence, Other, Racial Disparities|

Read More

• 

  Molecular profiles and clinical-pathological features of Asian early-stage breast cancer patients

  Gallery

  Molecular profiles and clinical-pathological features of Asian early-stage breast cancer patients

  Evidence, Other, Racial Disparities

Molecular profiles and clinical-pathological features of Asian early-stage breast cancer patients

PUBLICATION: SABCS 2020 AUTHORS: Margaret Chen, Ava Kwong, Carolyn Hendricks, Read More

kevin2024-03-25T08:02:55-04:00December 29th, 2020|Evidence, Other, Racial Disparities|

Read More

• 

  Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens

  Gallery

  Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens

  Evidence, Other, Validation

Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens

PUBLICATION: SABCS 2020 AUTHORS: Joseph McKelley, Jennifer Wei, Brian Hoxeng, Read More

kevin2024-03-25T08:01:39-04:00December 29th, 2020|Evidence, Other, Validation|

Read More